• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷及腺苷受体在多发性硬化症免疫发病机制中的作用

The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.

作者信息

Safarzadeh Elham, Jadidi-Niaragh Farhad, Motallebnezhad Morteza, Yousefi Mehdi

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Inflamm Res. 2016 Jul;65(7):511-20. doi: 10.1007/s00011-016-0936-z. Epub 2016 Mar 9.

DOI:10.1007/s00011-016-0936-z
PMID:26960979
Abstract

INTRODUCTION

Multiple sclerosis (MS) is a heterogeneous neurological disorder with multifactorial etiologies characterized by demyelination, axonal degeneration, and oligodendroglial death. It is believed that both genetics and environmental risk factors such as infection are involved in disease etiology. Accumulating evidence indicates that alteration in purinergic system signaling is involved in immunity and inflammation. Adenosine, a key purine nucleoside, has been shown to be produced during metabolic stress, including ischemia, inflammatory condition, and tissue injury.

METHODS

Extracellular adenosine directly affects various physiological and pathological processes of MS by stimulating G protein-coupled adenosine receptors A1, A2A, A2B, and A3 on the surface of immune cells. It has been suggested that promotion of adenosinergic system may be an important factor in MS pathophysiology and considered as promising therapeutic target for this disease.

CONCLUSION

In this review, we will discuss about the immunopathologic effects of adenosine on MS and its animal model, experimental autoimmune encephalomyelitis.

摘要

引言

多发性硬化症(MS)是一种异质性神经疾病,病因多因素,其特征为脱髓鞘、轴突变性和少突胶质细胞死亡。人们认为遗传因素和诸如感染等环境风险因素均参与疾病病因。越来越多的证据表明嘌呤能系统信号改变参与免疫和炎症过程。腺苷作为关键的嘌呤核苷,已证实在包括缺血、炎症状态和组织损伤等代谢应激期间产生。

方法

细胞外腺苷通过刺激免疫细胞表面的G蛋白偶联腺苷受体A1、A2A、A2B和A3,直接影响MS的各种生理和病理过程。有人提出促进腺苷能系统可能是MS病理生理学中的一个重要因素,并被视为该疾病有前景的治疗靶点。

结论

在本综述中,我们将讨论腺苷对MS及其动物模型实验性自身免疫性脑脊髓炎的免疫病理效应。

相似文献

1
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.腺苷及腺苷受体在多发性硬化症免疫发病机制中的作用
Inflamm Res. 2016 Jul;65(7):511-20. doi: 10.1007/s00011-016-0936-z. Epub 2016 Mar 9.
2
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis.腺嘌呤核苷信号在多发性硬化发病机制和治疗中的作用。
Front Immunol. 2022 Jul 28;13:946698. doi: 10.3389/fimmu.2022.946698. eCollection 2022.
3
Adenosine signaling and the immune system: When a lot could be too much.腺苷信号转导与免疫系统:过犹不及。
Immunol Lett. 2019 Jan;205:9-15. doi: 10.1016/j.imlet.2018.04.006. Epub 2018 Apr 24.
4
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated.多发性硬化症淋巴细胞上调 A2A 腺苷受体,当受到刺激时具有抗炎作用。
Eur J Immunol. 2013 Aug;43(8):2206-16. doi: 10.1002/eji.201343314. Epub 2013 Jun 3.
5
The role of the adenosinergic system in lung fibrosis.腺嘌呤核苷系统在肺纤维化中的作用。
Pharmacol Res. 2013 Oct;76:182-9. doi: 10.1016/j.phrs.2013.08.004. Epub 2013 Aug 28.
6
Adenosine and Inflammation: Here, There and Everywhere.腺苷与炎症:无处不在。
Int J Mol Sci. 2021 Jul 19;22(14):7685. doi: 10.3390/ijms22147685.
7
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.腺苷受体:炎症和免疫疾病的治疗方面
Nat Rev Drug Discov. 2008 Sep;7(9):759-70. doi: 10.1038/nrd2638.
8
Adenosine regulation of the immune response initiated by ischemia reperfusion injury.腺苷对缺血再灌注损伤引发的免疫反应的调节作用。
Perfusion. 2016 Mar;31(2):103-10. doi: 10.1177/0267659115586579. Epub 2015 May 18.
9
Immunopathogenesis of multiple sclerosis.多发性硬化症的免疫发病机制。
Clin Immunol. 2012 Jan;142(1):2-8. doi: 10.1016/j.clim.2011.03.004. Epub 2011 Mar 12.
10
Adenosine receptors in cerebral ischemia.脑缺血中的腺苷受体
Int Rev Neurobiol. 2014;119:309-48. doi: 10.1016/B978-0-12-801022-8.00013-1.

引用本文的文献

1
Intrinsic ecto-5'-Nucleotidase/AR Coupling may Confer Neuroprotection to the Cerebellum in Experimental Autoimmune Encephalomyelitis.内在的ecto-5'-核苷酸酶/AR 偶联可能为实验性自身免疫性脑脊髓炎中的小脑提供神经保护作用。
Mol Neurobiol. 2024 Nov;61(11):9284-9301. doi: 10.1007/s12035-024-04174-9. Epub 2024 Apr 15.
2
Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.细胞外嘌呤代谢——多发性硬化症的潜在靶点。
Mol Neurobiol. 2024 Oct;61(10):8361-8386. doi: 10.1007/s12035-024-04104-9. Epub 2024 Mar 18.
3
Single-Cell Sequencing Combined with Transcriptome Sequencing Constructs a Predictive Model of Key Genes in Multiple Sclerosis and Explores Molecular Mechanisms Related to Cellular Communication.

本文引用的文献

1
Update on immunopathogenesis and immunotherapy in multiple sclerosis.多发性硬化症免疫发病机制与免疫治疗的最新进展
Immunotargets Ther. 2013 Apr 25;2:21-30. doi: 10.2147/ITT.S31813. eCollection 2013.
2
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.腺苷2A受体激动作用:鞘内单次给药可减轻大鼠实验性自身免疫性脑病中的运动麻痹。
Brain Behav Immun. 2015 May;46:50-4. doi: 10.1016/j.bbi.2015.01.014. Epub 2015 Jan 31.
3
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
单细胞测序联合转录组测序构建多发性硬化关键基因预测模型并探索细胞通讯相关分子机制
J Inflamm Res. 2024 Jan 9;17:191-210. doi: 10.2147/JIR.S442684. eCollection 2024.
4
Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.中国虫草:生物活性成分、抗肿瘤作用及其作用机制研究进展。
Molecules. 2022 Oct 4;27(19):6576. doi: 10.3390/molecules27196576.
5
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis.腺嘌呤核苷信号在多发性硬化发病机制和治疗中的作用。
Front Immunol. 2022 Jul 28;13:946698. doi: 10.3389/fimmu.2022.946698. eCollection 2022.
6
Adenosine and Inflammation: Here, There and Everywhere.腺苷与炎症:无处不在。
Int J Mol Sci. 2021 Jul 19;22(14):7685. doi: 10.3390/ijms22147685.
7
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.新型冠状病毒肺炎相关多发性硬化症中胆碱能和嘌呤能调节的抗炎治疗
Mol Neurobiol. 2021 Oct;58(10):5090-5111. doi: 10.1007/s12035-021-02464-0. Epub 2021 Jul 11.
8
Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?多发性硬化症中神经炎症与神经退行性变的关联:少突胶质前体细胞是疾病的关键环节吗?
Front Cell Neurosci. 2021 Jun 21;15:654284. doi: 10.3389/fncel.2021.654284. eCollection 2021.
9
Downregulation of CD73/AR-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis.CD73/AR介导的腺苷信号下调作为θ波爆发式经颅磁刺激对急性实验性自身免疫性脑脊髓炎神经保护作用的潜在机制
Brain Sci. 2021 Jun 1;11(6):736. doi: 10.3390/brainsci11060736.
10
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis.脑脊液蛋白质组显示多发性硬化症中神经元发育紊乱。
Sci Rep. 2021 Feb 18;11(1):4087. doi: 10.1038/s41598-021-82388-w.
间充质干细胞的免疫调节特性及其在多发性硬化症治疗中的作用。
Cell Immunol. 2015 Feb;293(2):113-21. doi: 10.1016/j.cellimm.2015.01.002. Epub 2015 Jan 10.
4
Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.多发性硬化症中中枢神经系统的免疫监视——对治疗和实验模型的相关性
J Neuroimmunol. 2014 Nov 15;276(1-2):9-17. doi: 10.1016/j.jneuroim.2014.08.622. Epub 2014 Aug 30.
5
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.多发性硬化症的发病机制:分子和代谢成像的新见解。
Lancet Neurol. 2014 Aug;13(8):807-22. doi: 10.1016/S1474-4422(14)70101-2. Epub 2014 Jul 6.
6
The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.基质金属蛋白酶在多发性硬化症免疫发病机制及治疗中的意义
Sultan Qaboos Univ Med J. 2014 Feb;14(1):e13-25. doi: 10.12816/0003332. Epub 2014 Jan 27.
7
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.优化多发性硬化症患者管理中的治疗方法:药物疗效、剂量及作用机制综述
Biologics. 2013;7:247-58. doi: 10.2147/BTT.S53007. Epub 2013 Nov 27.
8
Initial immunopathogenesis of multiple sclerosis: innate immune response.多发性硬化的初始免疫发病机制:固有免疫反应。
Clin Dev Immunol. 2013;2013:413465. doi: 10.1155/2013/413465. Epub 2013 Sep 24.
9
Commentary: research highlights: Inflammation, demyelination and neurodegeneration: risky buddies in multiple sclerosis.
CNS Neurol Disord Drug Targets. 2014 Feb;13(1):4-5. doi: 10.2174/18715273113126660148.
10
Commentary: Never underestimate the power of adenosine in multiple sclerosis.
CNS Neurol Disord Drug Targets. 2013 Nov;12(7):895-6. doi: 10.2174/187152731207131125104215.